Stock Market Opening Bell: Sensex Fell 0.55%, Nifty 50 Declined 0.53% - Here's Why

Stock Market Opening Bell: The Indian stock market benchmark indices, Sensex and Nifty 50, witnessed  gap down opening on Thursday, tracking weakness in global markets, and rising tensions linked to the US-Iran war, which kept crude oil prices and inflations concerns elevated.

While Sensex declined 0.55% to 73935.80, Nifty 50 plummeted 0.23% to 0.53%.

The trends on Gift Nifty indicated a negative start for the Indian benchmark indices. The Gift Nifty was trading around 23,315 level, a discount of nearly 200 points from the Nifty futures’ previous close.

On Wednesday, BSE Sensex ended at 74,346.17, declining by 303.67 points (-0.41%) after witnessing a gap-down opening and sustained selling pressure during the first half of the session. However, strong buying interest emerged near lower levels, enabling the index to recover significantly from its intraday low and close well above the day’s bottom, reflecting resilience among market participants.

Meanwhile, Nifty 50 formed a small-bodied bearish candle with a long lower shadow on the daily chart, reflecting buying interest at lower levels despite heightened volatility. However, the index failed to surpass the previous session’s high, and the prevailing lower high–lower low structure remained intact, indicating continued weakness in the broader trend. 

Also Read: Oil Falls as Lebanon and Israel Agree to Implement Ceasefire

Stocks In Focus On June 4

BHEL secured a ₹2,000–2,500 crore order from Dangote Refinery, Nigeria, for gas turbine generators and associated commissioning services.

Hero MotoCorp launched India's first 100cc flex-fuel motorcycles— Splendor+ and HF Deluxe.

JBM Auto emerged as India's top electric bus player with a 49% market share in May 2026.

Steel Strips Wheels announced the retirement of Deputy Managing Director Mohan Joshi effective June 3.

LTM launched a new AI-powered managed Secure Service Edge (SSE) solution in partnership with Cisco.

Indiabulls approved raising up to ₹1,000 crore through preferential issue of warrants at ₹19.40 per share.

Aurobindo Pharma inaugurated TheraNym, one of India's largest biologics contract manufacturing facilities.